Results 91 to 100 of about 257,914 (221)

Age-Markers on the Red Blood Cell Surface and Erythrocyte Microparticles may Constitute a Multi-parametric Strategy for Detection of Autologous Blood Transfusion. [PDF]

Sports Med Open, 2023
Biasini GM, Botrè F, de la Torre X, Donati F.   +3 more
europepmc   +1 more source

Narrative review of strategies for blood product shelf‐life extension

Transfusion, EarlyView.
Mike Akaraphanth, Jessica Oudakker, Matthew Paulson, Michael Adam Meledeo, Kristin M. Reddoch‐Cardenas, Lusha Xiang, Steven G. Schauer, Todd Getz   +7 more
wiley   +1 more source

Understanding donor behaviour following a deferral for low haemoglobin: A cross‐sectional survey study

Vox Sanguinis, EarlyView.
Abstract Background and Objectives While deferral due to low haemoglobin (Hb) is known to affect donor return, how donors react to and manage low Hb is less well understood. This paper aims to (1) describe donor activities to manage low Hb, and (2) examine donor knowledge, recalled emotions, satisfaction and potential concerns, and to determine their ...
Amanda Thijsen, Marijke Welvaert, Peter Bentley, Joanna Speedy   +3 more
wiley   +1 more source

Autologous blood transfusion reduces the requirement for perioperative allogenic blood transfusion in patients undergoing major hepatopancreatobiliary surgery: a retrospective cohort study. [PDF]

Int J Surg, 2023
Lakha AS, Chadha R, Von-Kier S, Barbosa A, Maher K, Pirkl M, Stoneham M, Silva MA, Soonawalla Z, Udupa V, Reddy S, Gordon-Weeks A.   +11 more
europepmc   +1 more source

Association of red blood cell transfusions with periventricular leukomalacia in very preterm infants

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Red blood cell (RBC) transfusions have been associated with retinopathy of prematurity (ROP) and adverse long‐term neurodevelopmental outcomes in very preterm infants. Although lower transfusion thresholds reduce the incidence of ROP, they have not improved neurological outcome. Periventricular leukomalacia (PVL) is a
Thomas Brune, Christian Weise, Siegfried Kropf   +2 more
wiley   +1 more source

The Comparison of Acute Normovolemic Hemodilution with Allogenic Blood Transfusion in Patients who Underwent Femoral Fracture Surgery

Archives of Anesthesia and Critical Care, 2015
Background: Acute normovolemic hemodilution is an available technique to decrease the side effects of allogenic blood transfusion. The aim of this study was to compare acute normovolemic hemodilution with allogenic blood transfusion in adult patients who
Ebrahim Khoshraftar, Hassan Mohammadi Poor Anvari, Mohammad Hossein Bakhshaei, Nahid Manouchehrian, Mohammad Sadegh Sanie Jahromi   +4 more
doaj  

Bone Regeneration Using Cotton‐Like Artificial Bone Seeded With Bone Marrow Cells

Oral Science International, Volume 23, Issue 2, May 2026.
ABSTRACT Objective Autologous bone grafts using the iliac crest or fibula are considered standard treatment for jawbone defects and cleft palate, but these approaches are clinically not considered to be mild invasion, and there is a risk of complications at the donor site.
Rintaro Narita, Hiroko Komura, Yen‐Chih Huang, Kohei Shiraishi, Takafumi Harada, Arhans Chairul Ismael, Tamami Denda, Yasunori Ota, Yukiyo Asawa, Tokiko Nagamura, Kazuto Hoshi, Makoto Komura   +11 more
wiley   +1 more source

Untargeted Metabolomics Identifies a Novel Panel of Markers for Autologous Blood Transfusion. [PDF]

Metabolites, 2022
Al-Nesf A, Mohamed-Ali N, Acquaah V, Al-Jaber M, Al-Nesf M, Yassin MA, Orie NN, Voss SC, Georgakopoulos C, Bhatt R, Beotra A, Mohamed-Ali V, Al-Maadheed M.   +12 more
europepmc   +1 more source

Manufacturing and clinical applications of non‐CAR‐T immune effector cells

Transfusion, EarlyView.
Thane Kubik, Theodros Mamo, David H. McKenna   +2 more
wiley   +1 more source

Exploring Affordable Curative Therapy for Sickle Cell Disease in Africa: A Comprehensive Overview

American Journal of Hematology, Volume 101, Issue S1, Page 56-74, April 2026.
ABSTRACT The practical aspects of developing curative treatments for sickle cell disease (SCD) in Africa, such as gene therapy and hematopoietic stem cell transplantation, involve strengthening healthcare infrastructure, training healthcare professionals, establishing regional treatment centers, and creating national SCD programs.
Adetola A. Kassim, Alexis A. Thompson, Punam Malik   +2 more
wiley   +1 more source